Published in Monoclonal Antibodies Weekly, May 17th, 2000
"Context, knowledge, and understanding of gram-negative sepsis have grown over the past 20 years, but the ability to treat severe sepsis successfully has not," wrote D.C. Angus and colleagues, University of Pittsburgh, Pennsylvania.
Angus et al. published their study in the Journal of the American Medical Association ("E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial," JAMA, 2000;283(13):1723-1730).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Monoclonal Antibodies Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.